Factors influencing reduction in blood pressure and left ventricular mass in hypertensive type-1 diabetic patients using captopril or doxazosin for 6 months

American Journal of Hypertension

Volumn 11, Issue 10 I, 1998, Pages 1178-1187

  Gerdts, Eva ^a   Svarstad, E ^a   Aanderud, S ^a   Myking, O L ^a   Lund Johansen, P ^a   Omvik, P ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Atrial natriuretic peptide; Captopril; Dietary sodium intake; Doxazosin; Hypertension; Insulin dependent diabetes mellitus; Left ventricular hypertrophy

Indexed keywords

ALBUMIN; ATRIAL NATRIURETIC FACTOR; CAPTOPRIL; DOXAZOSIN; GLYCOSYLATED HEMOGLOBIN; INSULIN; SODIUM;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; MALE; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; SODIUM INTAKE;

ADULT; ALBUMINURIA; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CAPTOPRIL; DIABETES MELLITUS, TYPE 1; DOXAZOSIN; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS;

EID: 0031727691     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00194-0     Document Type: Article

References (49)

1. Grossman E, Shemesh J, Shamiss A, et al: Left ventricular mass in diabetes hypertension. Arch Intern Med 1992;152:1001-1004.
2. Noergaard K, Feldt-Rasmussen B, Borch-Johnsen K, et al: Prevalence of hypertension in type-1 (insulin-dependent) diabetes mellitus. Diabetologia 1990;33:407-410.
3. Gerdts E, Myking OL, Lund-Johansen P, Omvik P: Factors influencing LVM in hypertensive type-1 diabetic patients. Blood Pressure 1997;6:197-202.
4. Devereux RB, de Simone G, Ganau A, Roman MJ: Left ventricular hypertrophy and geometric remodelling in hypertension: stimuli, functional consequences and prognostic implications. J Hypertens 1994;12(suppl 10): S117-S127.
5. Van Hoeven KH, Factor SM: A comparison of the pathological spectrum of hypertensive, diabetic and hypertensive-diabetic heart disease. Circulation 1990; 82:848-855.
6. Tuck ML, Corry D, Trujillo A: Salt sensitive blood pressure and exaggerated vascular reactivity in the hypertension of diabetes mellitus. Am J Med 1990;88: 210-216.
7. Tuck ML: Role of salt in the control of blood pressure and diabetes mellitus. Hypertension 1991;17(suppl I):I-135-I-142.
8. Galderisi M, Anderseon KM, Wilson PWF, Levy D: Echocardiographic evidence of the existence of a distinct diabetic cardiomyopathy. Am J Cardiol 1991;68: 85-89.
9. Beretta-Piccoli C, Weidmann P: Exaggerated pressor responsiveness to norepinephrine in nonazotemic diabetes mellitus. Am J Med 1981;71:829-835.
10. Dahlöf B, Pennert K, Hansson L: Reversal of left ventricular hypertrophy in hypertensive patients: a metaanalysis of 109 treatment studies. Am J Hypertens 1992; 5:95-110.
11. Khan N, Couper J, Dixit M, Couper R: Ambulatory blood pressure and heart rate in adolescents with insulin-dependent diabetes mellitus. Am J Hypertens 1994;7:937-940.
12. Poulsen PL, Hansen KW, Mogensen CE: Ambulatory blood pressure in the transition from normo- to microalbuminuria; a longitudinal study in IDDM patients (abst). Diabetologia 1993;36(suppl 1):A214.
13. Mogensen CE: Renoprotective role of ACE inhibitors in diabetic nephropathy. Br Heart J 1994;72:S38-S45.
14. Parving HH, Hommel E, Mathisen E, et al: Protection in kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. Br Med J 1988;296:156-160.
15. Neaton JD, Grimm JRH, Prineas RJ, et al: Treatment of mild hypertension study: final results. JAMA 1993;270: 713-724.
16. Corral JL, Lopez NC, Pecorelli A, et al: Doxazosin in the treatment of mild or moderate essential hypertension: an echocardiographic study. Am Heart J 1991;121:352-356.
17. Agabiti-Rosei E, Muiesan ML, Rizzoni D, et al: Reduction of left ventricular hypertrophy after longterm antihypertensive treatment with doxazosin. J Hum Hypertens 1992;6:9-15.
18. Winocour PH, Catalano C, New J, Alberti KGMM: Contrasting renal and metabolic effects of alpha- and beta-adrenergic blockade in mildly hypertensive type-1 (insulin dependent) diabetic subjects. Nutr Metab Cardiovasc Dis 1995;5:217-224.
19. 1-antagonist on albuminuria in insulin-dependent diabetes mellitus patients with nephropathy. J Intern Med 1995; 237:63-71.
20. Svarstad E, Gerdts E, Omvik P, et al: Captopril and doxazosin induce similar changes in renal hemodynamics in ambulatory hypertensive patients with insulin dependent diabetes mellitus (IDDM). J Am Soc Nephrol 1995;6:650.
21. Sahn DJ, DeMaria A, Kisslo J, Weyman A, and The committee on M-mode standardization of the American Society of Echocardiography: Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1081.
22. Devereux RB, Alonso DR, Lutas EM, et al: Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57:450-458.
23. White WB, Lund-Johansen P, Omvik P: Assessment of four ambulatory blood pressure monitors and measurements by clinicians versus intraarterial blood pressure at rest and during exercise. Am J Cardiol 1990;65: 60-66.
24. Luft FC, Fineberg NC, Sloan RS: Estimating dietary sodium intake in individuals receiving a randomly fluctuating intake. Hypertension 1982;4:805-808.
25. Mo R, Myking OL, Lund-Johansen P, Omvik P: The Bergen Blood Pressure Study: inappropriate low levels of circulating atrial natriuretic peptide in offspring of hypertensive families. Blood Pressure 1993;2:197-204.
26. SPSS for Windows, Base System User's Guide, Release 6.0, 1993; SPSS Inc., Chicago.
27. Schmieder RE, Messerli FH, Rüddel H, et al: Sodium intake modulates left ventricular hypertrophy in essential hypertension. J Hypertens 1988;6(suppl 4):S148-S150.
28. Langenfeld MRW, Schmieder RE: Salt and left ventricular hypertrophy: what are the links? J Hum Hypertens 1995;9:909-916.
29. Blake J, Devereux RB, Borer JS, et al: Relation of obesity, high sodium intake, and eccentric left ventricular hypertrophy to left ventricular exercise dysfunction in essential hypertension. Am J Hypertens 1990;88:477-485.
30. Ferrara LA, De Simone G, Pasanisi F, Mancini M: Left ventricular mass reduction during salt depletion in arterial hypertension. Hypertension 1984;6:755-759.
31. Omvik P, Lund-Johansen P, Eide R: Sodium excretion and blood pressure in middleaged men in the Sogn county: an intra- and interpopulation study. J Hypertens 1983;1:77-83.
32. White WB, Schulman P, McCabe EJ, Dey HM: Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension. JAMA 1989;261:873-877.
33. Berrut G, Hallab M, Bouhanick B, et al: Value of ambulatory blood pressure monitoring in type-1 (insulin-dependent) diabetic patients with incipient diabetic nephropathy. Am J Hypertens 1994;7:222-227.
34. Pickering TG, Levenstein M, Walmsley P: Nighttime dosing of doxazosin has peak effect on morning ambulatory blood pressure. Am J Hypertens 1994;7:844-847.
35. Mogensen CE: Management of the diabetic patient with elevated blood pressure or renal disease, in Laragh JH and Brenner BM (eds): Hypertension: Pathophysiology, Diagnosis and Management, 2nd ed. Raven Press Ltd., New York, 1995; pp 2335-2360.
36. National High Blood Pressure Education Program Working Group: National high blood pressure education program working group report on hypertension in diabetes. High Blood Press 1995;4:253-271.
37. The Diabetes Control and Complication Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
38. Ferris JB, O'Hare JA, Kelleher CCM, et al: Diabetic control and the renin angiotensin system, catecholamines and blood pressure. Hypertension 1985; 7(suppl 2):II58-II63.
39. Bhanot S, McNeill JH: Insulin and hypertension: a causal relationship? Cardiovasc Res 1996;31:212-221.
40. Fioretto P, Muollo B, Faronato PP, et al: Relationships among natriuresis, atrial natriuretic peptide and insulin in insulin-dependent diabetes. Kidney Int 1992;41:813-821.
41. Nosadini R, Fioretto P, Giorato C, et al: Sodium metabolism in insulin dependent diabetic patients: role of insulin and atrial natriuretic peptide. Diabetes Metab 1989;15:301-305.
42. Tedde R, Sechi LA, Marigliano A, et al: Antihypertensive effect of insulin reduction in diabetic hypertensive patients. Am J Hypertens 1989;2:163-170.
43. Powrie JK, Watts GF, Taub NA, et al: Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes. Br Med J 1994; 309:1608-1612.
44. Scheffer Z, Peleg E, Landau-Salzberg M, Rosenthal T: Atrial natriuretic peptide in diabetic patients before and after control of blood sugar level. J Cardiovasc Pharmacol 1991;18:878-881.
45. Ferri C, Piccoli A, Laurent O, et al: Atrial natriuretic peptide in hypertensive and normotensive diabetic patients. Diabetes Care 1994;17:195-200.
46. Bell GM, Bernstein RK, Laragh JH, et al: Increased plasma atrial natriuretic factor and reduced plasma renin in patients with poorly controlled diabetes mellitus. Clin Sci 1989;77:177-182.
47. Sagnella GA, Markandu AC, MacGregor GA: Plasma immunoreactive atrial natriuretic peptide and changes in dietary sodium intake in man. Life Sci 1986;40:139-143.
48. de Bold AJ, Bruneau BG, Kuroski de Bold ML: Mechanical and neuroendocrine regulation of the endocrine heart. Cardiovasc Res 1996;68:85-89.
49. Ganau A, Devereux RB, Atlas SA, et al: Plasma atrial natriuretic peptide in essential hypertension: relation to cardiac size, function and systemic hemodynamics. J Am Coll Cardiol 1989;14:715-724.